Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Thursday, October 02, 2008
ImClone - it's Lilly
Eli Lilly has emerged as the mystery “large pharmaceutical company” that Carl Icahn, the chairman of ImClone, has said was prepared to acquire his biotechnology group for about $6.1 billion (£3.5 billion), or $70 a share.
No comments:
Post a Comment